The location of multiple pharmaceutical companies in close vicinity can have both positive and negative consequences. On the one hand, this aggregation of expertise can stimulate innovation and enhance research and development. Companies in close vicinity can partner more smoothly, sharing resources, knowledge, and laboratories. This can lead to t